Journal
SCIENTIFIC REPORTS
Volume 6, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/srep37815
Keywords
-
Categories
Funding
- Kitasato University Medical Center
- MEXT
- Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics
- P-DIRECT (Project for Development of Innovative Research on Cancer Therapeutics) grant from The Japan Agency for Medical Research and Development
- SENSHIN Medical Research Foundation
- Grants-in-Aid for Scientific Research [15K06829] Funding Source: KAKEN
Ask authors/readers for more resources
Influenza virus (IFV) infection is a common cause of severe pneumonia. Studies have suggested that excessive activation of the host immune system including macrophages is responsible for the severe pathologies mediated by IFV infection. Here, we focused on the X11 protein family member Mint3/Apba3, known to promote ATP production via glycolysis by activating hypoxia inducible factor-1 (HIF-1) in macrophages, and examined its roles in lung pathogenesis and anti-viral defence upon IFV infection. Mint3-deficient mice exhibited improved influenza pneumonia with reduced inflammatory cytokines/chemokine levels and neutrophil infiltration in the IFV-infected lungs without alteration in viral burden, type-I interferon production, or acquired immunity. In macrophages, Mint3 depletion attenuated NF-kappa B signalling and the resultant cytokine/chemokine production in response to IFV infection by increasing I kappa B alpha and activating the cellular energy sensor AMPK, respectively. Thus, Mint3 might represent one of the likely therapeutic targets for the treatment of severe influenza pneumonia without affecting host anti-viral defence through suppressing macrophage cytokine/chemokine production.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available